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Haemophilus ducreyi is the etiologic agent of the sexually transmitted genital ulcer disease chancroid. In both natural and exper-
imental chancroid, H. ducreyi colocalizes with fibrin at the base of the ulcer. Fibrin is obtained by cleavage of the serum glyco-
protein fibrinogen (Fg) by thrombin to initiate formation of the blood clot. Fg binding proteins are critical virulence factors in
medically important Gram-positive bacteria. H. ducreyi has previously been shown to bind Fg in an agglutination assay, and the
H. ducreyi Fg binding protein FgbA was identified in ligand blotting with denatured proteins. To better characterize the interac-
tion of H. ducreyi with Fg, we examined Fg binding to intact, viable H. ducreyi bacteria and identified a novel Fg binding pro-
tein. H. ducreyi bound unlabeled Fg in a dose-dependent manner, as measured by two different methods. In ligand blotting with
total denatured cellular proteins, digoxigenin (DIG)-Fg bound only two H. ducreyi proteins, the trimeric autotransporter DsrA
and the lectin DltA; however, only the isogenic dsrA mutant had significantly less cell-associated Fg than parental strains in Fg
binding assays with intact bacteria. Furthermore, expression of DsrA, but not DltA or an empty vector, rendered the non-Fg-
binding H. influenzae strain Rd capable of binding Fg. A 13-amino-acid sequence in the C-terminal section of the passenger do-
main of DsrA appears to be involved in Fg binding by H. ducreyi. Taken together, these data suggest that the trimeric autotrans-
porter DsrA is a major determinant of Fg binding at the surface of H. ducreyi.
The Gram-negative bacterium Haemophilus ducreyi is the caus-ative agent of the sexually transmitted genital ulcer disease
chancroid (reviewed in references 1 to 3). Chancroidal lesions are
soft, purulent, and painful ulcers that bleed easily upon contact (3,
4). In both natural and experimental chancroid, H. ducreyi is
found mostly in the dermis, colocalizing with neutrophils and
fibrin, but it can also be found in the extracellular space of the
epidermis (5, 6). Survival of H. ducreyi in this hostile environment
is thought to be dependent on many factors, including resistance
to phagocytosis and to the bactericidal activity of normal human
serum (NHS). One outer membrane protein (OMP) of H. ducreyi,
the ducreyi serum resistance A (DsrA) protein, has been shown to
be involved in serum resistance by preventing binding of naturally
occurring IgM at its surface (7, 8). DsrA is required for full viru-
lence in human experimental H. ducreyi infection (9).
DsrA belongs to the family of trimeric autotransporter adhesin
(TAA), multifunctional outer membrane proteins involved in ad-
hesion and serum resistance (10). Structurally, TAA proteins con-
tain three domains: an N-terminal signal peptide, a passenger do-
main, and a C-terminal translocator region (11). The highly
conserved translocator domain of TAA, which serves as the crite-
rion for inclusion of proteins in this family, anchors TAA in the
outer membrane. The passenger domain of TAA is involved in its
different functions. As the name implies, TAA proteins are ex-
pressed as trimers at the surface of bacterial cells, and trimeriza-
tion of the passenger domain is required for structural stability,
adhesive activity, and virulence (12, 13). The prototypical protein
for this group of proteins, YadA from Yersinia enterocolitica, is
lollipop shaped, with the head of YadA forming the lollipop por-
tion. In YadA, both fibronectin (Fn) and collagen binding do-
mains are found in the head section (14). DsrA does not bind
collagen but interacts with Fn and vitronectin (Vn) (15, 16). Fn
and Vn binding are mediated by amino acids in the C-terminal
region of the DsrA passenger domain (17).
There are two clonal populations of H. ducreyi strains, termed
class I and class II (18–21), based on variant outer membrane
determinants, including DsrA (18–21). Each class of H. ducreyi
strains expresses a different DsrA protein, termed DsrAI and
DsrAII for class I and class II strains, respectively (18). Despite low
homology in their passenger domains, the two classes of DsrA
proteins possess the same functions: both DsrAI and DsrAII confer
serum resistance and Fn and Vn binding (16).
Fibrinogen (Fg) is a large serum glycoprotein involved in co-
agulation, wound healing, neoplasia, angiogenesis, and the in-
flammatory response (22, 23). Fg interacts with the extracellular
matrix (ECM) and cells. The 340-kDa Fg molecule is composed of
three nonidentical peptide chains, termed , , and , pairs of
which are joined together by disulfide bonds (23). Fg binding
proteins of Gram-positive bacteria have been well characterized
and have been shown to be involved in pathogenesis (24, 25);
however, there is less evidence about the presence of Fg binding
proteins in Gram-negative bacteria and their role in disease. H.
ducreyi was first shown to interact with Fg in a latex bead aggluti-
nation assay, where all 21 isolates tested bound Fg (26). In 2009, a
lipoprotein termed FgbA (HD0192) was shown to bind digoxige-
nin (DIG)-Fg in ligand blotting of denatured proteins from pro-
totypical class I H. ducreyi strain 35000HP. FgbA was shown to be
involved in the pathogenesis of experimental chancroid (27). Be-
cause H. ducreyi colocalizes with fibrin in both natural and exper-
imental chancroid, we sought to identify the cell surface receptor
of H. ducreyi that interacts with the precursor of fibrin, Fg. In two
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different binding assays using intact bacterial cells, only H. ducreyi
lacking expression of dsrA had significantly reduced amounts of
cell-associated Fg compared to the wild-type parental strain. Fur-
thermore, complementation of an isogenic dsrA mutant restored
Fg binding and conferred binding to a Haemophilus influenzae
strain incapable of binding Fg. A 13-amino-acid sequence in the
translocator domain of DsrA was shown to be involved in the
interaction of Fg at the surface of H. ducreyi cells. Our findings
indicate that Fg interacts specifically and in a dose-dependent
manner with DsrA at the surface of viable H. ducreyi cells.
MATERIALS AND METHODS
Bacterial strains and culture conditions. H. ducreyi strains (Table 1)
were routinely cultured and passaged on chocolate agar plates (CAP) con-
taining GC medium base (Difco, Detroit, MI) and 1% bovine hemoglobin
(Becton, Dickinson, Sparks, MD), supplemented with 5% FetalPlex
(Gemini Bio-Products, West Sacramento, CA) and 1 GGC (0.1% glu-
cose, 0.001% glutamine, 0.026% cysteine) (28) at 34.5°C in 5% CO2. H.
ducreyi strains were also cultured on heme plates containing GC medium
base and 50 g/ml heme (H5533; Sigma-Aldrich, St. Louis, MO) and
supplemented with 1 GGC. H. influenzae strains expressing different
plasmids (Table 1) were cultured on CAP supplemented with 1% IsoVi-
talex (BD, Franklin Lakes, NJ). Streptomycin (100 g/ml) was added to
the growth medium when appropriate.
Construction of in-frame dsrAI deletion mutants. To complement a
panel of truncated DsrA proteins already constructed (17), two more
in-frame dsrAI deletion mutants were created in the N-terminal region of
the passenger domain of DsrAI. Two forward primers, DsrAxH and
DsrAxI (Table 2), were each used separately in combination with primer
DsrAxE (17) and pUNCH1260 as the template to generate two separate
PCR products using the following conditions: 95°C for 5 min for 1 cycle,
followed by 30 cycles at 95°C for 1 min, 52°C for 1 min, and 72°C for 1
min, with a final polishing step at 72°C for 5 min. The products from these
PCRs (DsrAxH-E and DsrAxI-E) were digested overnight with XmaI,
cleaned, and ligated for 30 min at room temperature with XmaI-treated
pUNCH1424, as previously described (17), to form pUNCH2105 and
pUNCH2106, respectively.
Smaller deletions were also made in the passenger (pUNCH1764) and
translocator (pUNCH1706 and pUNCH1707) domains of DsrA. For each
of these three constructs, overlap extension PCR with Pfx polymerase
(Grand Island, NY) was used to generate three separate PCR products.
Two separate PCRs were performed to generate the 5= and 3= portions of
the constructs, using primers 1 and 2 and primers 3 and 4 (Table 2),
respectively, with the appropriate primers 2 and 3 used for each construct.
pUNCH1260 was used as the DNA template. The conditions for the first
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant genotype and/or phenotypea DsrAI protein expressed
Reference(s) or
source
Strains
H. ducreyi
35000HP Wild-type, human-passaged variant of strain 35000 DsrAI 37, 38
35000HP dsrA (FX517) 35000HP dsrA::CAT No DsrAI 7
35000HP ncaA 35000HP ncaA::CAT DsrAI 30
35000HP dltA 35000HP dltA::kan DsrAI 29
35000HP momp 35000HP momp::Km2; 35000HP-SMS2 DsrAI 39
35000HPompA2 35000HP ompA2::Kan2; 35000HP-SMS3 DsrAI 16
35000HP ftpA 35000HP ftpA::mTn3(Cm); 35000HP-SMS1 DsrAI 39
35000HP fgbA 35000HP fgbA::kan DsrAI 27
HMC21 (425) Wild type DsrAI 8
HMC21dsrA (FX529) HMC21dsrA::CAT No DsrAI 8
HMC50 (010-2) Wild type DsrAI 8
HMC50dsrA (FX530) HMC50dsrA::CAT No DsrAI 8
HMC54 Wild type DsrAI 8
HMC54dsrA HMC54dsrA::CAT No DsrAI 8
H. influenzae
Rd KW20 Wild type No DsrAI ATCC
Plasmids
pLSSK H. ducreyi shuttle vector; Smr No DsrAI 40
pUNCH1260 Complete dsrA ORF in pLSSK (774 bp; 257 amino acids) DsrAI 7
pUNCH1424 bp 73 to 510 deleted in dsrA DsrAI25–170 17
pUNCH1425 bp 73 to 474 deleted in dsrA DsrAI25–158 17
pUNCH1426 bp 73 to 438 deleted in dsrA DsrAI25–146 17
pUNCH1427 bp 73 to 399 deleted in dsrA DsrAI25–133 17
pUNCH1428 bp 73 to 363 deleted in dsrA DsrAI25–121 17
pUNCH1429 bp 73 to 330 deleted in dsrA DsrAI25–110 17
pUNCH1430 bp 73 to 291 deleted in dsrA DsrAI25–97 17
pUNCH1431 bp 73 to 195 deleted in dsrA DsrAI25–65 17
pUNCH1706 Deletion of MEQNTHNINKLS from DsrAI DsrAIMEQNTHNINKLS This study
pUNCH1707 Deletion of NTHNINKLSKEL from DsrAI DsrAINTHNINKLSKEL This study
pUNCH1764 Deletion of LKVLDARISKNKQ from DsrAI DsrAILKVLDARISKNKQ This study
pUNCH2105 bp 73 to 156 deleted in dsrA DsrAI25–51 This study
pUNCH2106 bp 73 to 123 deleted in dsrA DsrAI25–42 This study
a CAT, chloramphenicol acetyltransferase; Cm, chloramphenicol; Km2, Kan2 or kan, kanamycin resistance cassette; ORF, open reading frame.
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two PCRs were as follows: for the 5= region, 1 cycle at 95°C for 2 min,
followed by 30 cycles of denaturation (95°C, 15 s), annealing (43°C for
pUNCH1706, 43°C for pUNCH1707, and 45°C for pUNCH1764) for 30 s,
and extension (68°C, 1 min), with a final 1-cycle polishing step at 68°C for
5 min; for the 3= region, the conditions for PCRs were identical to those
for the 5= region, except that the annealing step was carried out at 41°C for
pUNCH1707. The third PCR was use to make the final construct contain-
ing the 5= and 3= regions next to the deletion. For this reaction, primers 1
and 4 were used with PCR products obtained with the first and second
PCRs as templates. The conditions for this last PCR are identical to those
described above, except that the annealing step for all of the constructs was
performed at 45°C, and the extension step lasted 90 s instead of 60 s.
All PCR products were subsequently ligated and electroporated into
the single isogenic dsrA mutant FX517 (7). Clones expressing recombi-
nant proteins of the expected size were selected based on protein expres-
sion, as determined by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and Coomassie blue staining. The DNA
sequence of the chosen clones was confirmed by sequencing at the Uni-
versity of North Carolina (UNC) sequencing facility. Expression of trun-
cated DsrA proteins at the surface of H. ducreyi cells was verified with a
rabbit polyclonal antibody (Ab) developed to the passenger domain of
DsrAI (rNT-DsrAI) in a whole-cell binding assay (17).
SDS-PAGE and Western and ligand blotting. Total cellular proteins
prepared from strains of H. ducreyi were subjected to SDS-PAGE under
reducing conditions (except for the experiment shown in Fig. 2) at 150 V
using a mini-Protean II system (Bio-Rad, Hercules, CA). Gels were trans-
ferred onto nitrocellulose membranes for 2 h at 200 mA and blocked
overnight in 0.5% Tween 20 in phosphate-buffered saline (PBS) (blocking
solution). Membranes were treated in either of two ways: ligand blotting
with DIG-labeled Fg (for the experiment shown in Fig. 2 only) or Western
blotting. For ligand blotting, 100 g of Fg (depleted of plasminogen, von
Willebrand factor, and Fn) (Enzyme Research Laboratories, South Bend,
IN) was labeled with DIG (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’s instructions. The membranes were there-
after incubated with DIG-Fg (1:10,000) in blocking solution for 1 h at
room temperature. After three washes with 0.05% Tween 20 in PBS (wash
buffer), the membranes were incubated with an anti-DIG secondary Ab
(Roche Diagnostics, Mannheim, Germany) for 1 h at room temperature
with mixing. After three more washes, the membranes were developed by
chemiluminescence using the substrate LumiPhosWB (Thermo Fisher Sci-
entific, Pittsburgh, PA). For Western blotting, membranes were incu-
bated with either anti-Fg (1:10,000; Sigma-Aldrich, St. Louis, MO) in the
Fg binding assay (described below), recombinant full-length DsrAI (rFL-
DsrAI) (18), or a polyclonal rabbit Ab to recombinant DltA (29) at a
dilution of 1:25,000 for 30 min at room temperature. After three washes,
the membranes were incubated with an anti-goat or anti-rabbit alkaline
phosphatase-conjugated secondary Ab (Sigma-Aldrich, St. Louis, MO)
for 30 min at room temperature and developed using chemiluminescence.
Fg binding assay. The Fg binding assay was carried out exactly as
described for the Fn binding assay (16), using suspensions of intact, viable
H. ducreyi bacteria and purified Fg; however, in this instance, cell-associ-
ated Fg was measured both by Western blotting and flow cytometry.
Briefly, suspensions (1 ml at an optical density at 600 nm [OD600] of 0.5;
approximately 2.5  108 CFU/ml) of bacteria grown on CAP or heme
plates (15 to 16 h) were prepared in GC broth (GCB) and incubated with
amounts of Fg indicated in Fig. 1 or the legends of the other figures for 30
min at 34.5°C (5% CO2 and humidified atmosphere), with mixing every
10 min. Bacterial cells were thereafter washed three times for 30 min with
GCB. The resulting pellet was transferred to a new microcentrifuge tube
and washed a fourth time. After the whole-cell binding assay, we assessed
Fg bound to the surface of H. ducreyi using two methods. Bacteria pellets
were suspended in Laemmli sample buffer with -mercaptoethanol, and a
3-l aliquot was subjected to SDS-PAGE (12%) and Western blotting
with anti-Fg as described above. We also used flow cytometry to assess H.
ducreyi-associated Fg. Bacterial suspensions were incubated with fluores-
cein isothiocyanate (FITC)-Fg (labeled according to the manufacturer’s
instructions) (FluoReporter FITC Protein Labeling Kit; Life Technolo-
gies, Grand Island, NY) as described above and analyzed using an Accuri
C6 Flow Cytometer (BD Biosciences, San Jose, CA). A total of 100,000
events were recorded, and a threshold of 10,000 was used. FCS Flow Cy-
tometry data analysis (De Novo Software, Los Angeles, CA) was used to
create the histograms from data obtained with the C6 cytometer.
For competition assays, Fg was first labeled with DIG (Roche Diagnos-
tics GmbH, Mannheim, Germany). Unlabeled Fg was then incubated with
suspensions of intact, viable H. ducreyi cell suspensions for 30 min prior to
addition of DIG-Fg. Cell-associated Fg was measured as described above.
Previous data from the unlabeled Fn binding assay as well as other unpub-
lished data from our laboratory indicate that the viability of H. ducreyi
cells is conserved after four washes of 30 min and that H. ducreyi can
survive at least 6 h at room temperature (data not shown). Therefore,
bacterial cells analyzed by flow cytometry were viable at the time of anal-
ysis.
Serum susceptibility. H. ducreyi resistance to 50% NHS was deter-
mined as previously described (18). Results are expressed as percent sur-
vival of H. ducreyi bacteria in fresh NHS compared to survival in heated
NHS (NHS) [(number of CFU in fresh NHS/number of CFU in
NHS)  100].
Densitometry and statistical analyses. Three bands on Western blots
were used for density measurements: the thick band above the 66.2-kDa
marker, which represents the  chain (63.5 kDa), and the doublet below
the 66.2-kDa molecular mass standard, which encompasses the  (56
kDa) and the  (47 kDa) chains of Fg. Density was determined using either
ImageJ (version 1.62 [http://rsb.info.nih.gov/nih-image/]) or AlphaVIEW
SA (version 3.2.4, build 1021 [ProteinSimple, Santa Clara, CA]). Data ob-
tained using densitometry were analyzed using a single sample t test using the
VassarStats website (http://vassarstats.net/). Binding was expressed as the
percentage of full-length wild-type (WT) DsrA or absence of competing un-
labeled protein, defined as 100% binding. A P value of 	0.05 was considered
statistically significant.
TABLE 2 List of primers
Name Sequence (5= to 3=) Construct(s)
DsrAxH TCCCCCGGGTTCGATATTAAAGTGCCAGGG pUNCH2105
DsrAxI TCCCCCGGGAAGGGTAAGTGGACTTGGTCT pUNCH2106
DsrA#1 GCGGGATCCCCCGACAGCATTCAGTG pUNCH1706, pUNCH1707, pUNCH1764
#2ND3 AGTTTGCAATTCTTTCATACGATAAGAATCATCTAAATA pUNCH1706
#3ND3 GATTCTTATCGTATGAAAGAATTGCAAACTGGTTTAGCC pUNCH1706
DsrA#4 GGCAAGCTTAATTAATAAAAGTGGC pUNCH1706, pUNCH1707, pUNCH1764
#2ND4 GGCTAAACCAGTTTGTTGTTCCATCATACGATAAGAATC pUNCH1707
#3ND4 CGTATGATGGAACAACAAACTGGTTTAGCCAACCAATCA pUNCH1707
SrDsrARev#2 TACATTCAAAATCTCATTAAGCCTATTCTTCGCTTGTAC pUNCH1764
SrDsrA2For#3 AAGAATAGGCTTAATGAGATTTTGAATGTAGGTAATCAT pUNCH1764
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RESULTS
Fg binds the surface of viable H. ducreyi bacteria in a dose-de-
pendent manner. We used an Fg binding assay using suspensions
of intact, viable bacteria and purified soluble plasma Fg, similar to
the one previously described for Fn binding (16), to determine if
purified Fg interacts with the surface of H. ducreyi cells. We de-
tected cell surface-bound Fg by Western blotting and flow cytom-
etry following Fg incubation with viable bacteria. In Western blot-
ting, proteins solubilized from viable bacteria incubated with Fg
were separated by SDS-PAGE and transferred onto nitrocellulose,
and H. ducreyi-bound Fg was identified with an anti-Fg Ab. For
flow cytometry, suspensions of H. ducreyi incubated with FITC-Fg
were assayed directly to detect FITC bound to the bacterial sur-
face. Because H. ducreyi binds Fn and because Fn interacts with Fg
(23), this study was performed using Fg depleted of plasminogen,
von Willebrand factor, and Fn to ensure that the interaction be-
tween H. ducreyi and Fg was not mediated via Fn or other factors
that bind Fg. Fg bound the surface of H. ducreyi in a dose-depen-
dent manner (Fig. 1A), as measured using Western blotting (top)
and flow cytometry (bottom).
We previously showed that the type of medium used for
growth affects Fn binding by H. ducreyi (16). Fn binding occurs
only on heme plates as hemoglobin blocks the interaction of Fn at
the surface of H. ducreyi. This was not the case for Fg binding as
results similar to those shown in Fig. 1A were obtained with bac-
teria grown on heme plates (data not shown). Thus, hemoglobin
does not block the interaction of Fg at the surface of H. ducreyi
cells.
In order to show specificity of Fg binding at the surface of H.
ducreyi bacteria, we used a competition assay with unlabeled and
DIG- or FITC-labeled Fg. Addition of increasing amounts of un-
labeled Fg prior to incubation of H. ducreyi with DIG- or FITC-Fg
reduced ligand binding to the bacterial cell surface (Fig. 1B). This
was consistent regardless of the method used to detect the inter-
action between Fg and H. ducreyi. Addition of excess irrelevant
ligand did not affect binding of DIG- or FITC-Fg to H. ducreyi
(data not shown).
DIG-Fg binds the H. ducreyi DsrA in ligand blotting. To
identify the bacterial proteins involved in Fg binding by H. du-
creyi, total cellular proteins from a panel of H. ducreyi strains,
including prototypical isolate 35000HP and isogenic mutants in
several OMPs (Table 1), were subjected to ligand blotting probed
with DIG-Fg. These mutants were chosen because their targeted
mutant proteins are either surface exposed and/or involved in
binding proteins of the ECM. DsrA and NcaA are two TAA pro-
teins expressed by H. ducreyi shown to interact with Fn/Vn and
collagen, respectively (16, 30). DltA is a lectin that binds Fn only in
ligand blotting but not in whole-cell binding assays (29). Also
included were mutants of the two major OMPs of H. ducreyi,
momp and ompA, since the former was shown to be involved in Fn
binding by H. ducreyi (16). Finally, an isogenic mutant lacking the
Fg binding protein FgbA (27) was also tested in the Fg binding
FIG 1 Fg interacts with H. ducreyi at its cell surface. Fg binding by intact, viable cells of H. ducreyi strain 35000HP was assessed using two different methods,
Western blotting with anti-Fg (top) and flow cytometry (bottom). (A) Standard curve with different amounts of Fg (top) or FITC-Fg (bottom) incubated with
intact H. ducreyi bacteria. (B) Competition assay with unlabeled and DIG- or FITC-labeled Fg. Viable bacteria of H. ducreyi strain 35000HP were incubated with
unlabeled Fg prior to incubation with DIG-labeled (Western blot, top) or FITC-labeled (flow cytometry, bottom) Fg. The numbers at the bottom of the blot refer
to densitometry of the Fg bands and indicate percent binding compared to results with no addition of unlabeled protein (0), defined as 100% binding. For all
Western blotting and flow cytometry experiments, representative blots and histograms from at least two independent experiments are shown. For Western
blotting, Ponceau S staining of the nitrocellulose membranes was performed to ensure equal loading of total proteins in all lanes (not shown).
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assay to determine if fgbA binds Fg at the bacterial surface. These
mutants were previously characterized for the absence of expres-
sion of the targeted protein (Table 1). The ligand blotting method
used in this single experiment is different from the Western blot
technique described above and used throughout these studies be-
cause interactions between DIG-Fg and H. ducreyi proteins occurs
in a denatured environment apart from the protein’s location in
H. ducreyi. Under nonreducing conditions, DIG-Fg bound the
TAA DsrA and the H. ducreyi lectin DltA (Fig. 2). DIG-Fg binding
to DltA was lost upon reduction with -mercaptoethanol (data
not shown). DIG-Fg did not bind FgbA, as previously reported
(27). These results suggest that both H. ducreyi DltA and DsrA
may bind Fg at the bacterial surface.
An H. ducreyi isogenic dsrA mutant binds significantly less
Fg at the cell surface than parental H. ducreyi 35000HP. To de-
termine whether Fg directly binds DsrA at the surface of H. ducreyi
cells, we tested the same panel of individual OMP mutants de-
scribed above using the Fg binding assay with intact, viable H.
ducreyi bacteria, assessing surface-associated Fg by Western blot-
ting and flow cytometry. Among this panel of H. ducreyi mutants
lacking demonstrated virulence factors, only the dsrA mutant
bound significantly less Fg than the parent strain 35000HP (67 to
95% reduction in Western blotting; P 	 0.05), whether the strains
were grown with or without hemoglobin (Fig. 3A and data not
shown). These results were confirmed by flow cytometry as
FITC-Fg binding to the surface of H. ducreyi cells was altered only
in the dsrA mutant (Fig. 3B). Binding by the 35000HP fgbA iso-
genic mutant strain in the previously identified Fg binding protein
FgbA was not significantly reduced compared to the level of
FIG 2 DIG-Fg binds to denatured DsrA. Total cellular proteins prepared from
a panel of H. ducreyi strains grown on CAP, including 35000HP and isogenic
mutant strains in this background, were subjected to ligand blotting with
DIG-Fg under nonreducing conditions. Shown is a representative blot from at
least two independent experiments. The location (molecular mass) of the dif-
ferent proteins on the blot is indicated using arrows (18, 27). The presence of
the indicated proteins on the blot was confirmed by Ponceau S staining prior to
incubation of the membrane with DIG-Fg.
FIG 3 DsrA is a major mediator of Fg binding by H. ducreyi. A panel of H. ducreyi strains, including prototypical class I isolate 35000HP and several isogenic
mutants, was subjected to the Fg binding assay. (A) Cell-associated Fg was measured by Western blotting. The mean band density, calculated from the three Fg
bands on Western blots obtained in three independent experiments, is indicated underneath the blots as a percentage of Fg binding by 35000HP, defined as 100%.
Bolded mean band density indicates significantly reduced Fg binding compared to strain 35000HP (P 	 0.05). Ponceau S staining of the nitrocellulose
membranes and Western blotting using antisera to full-length DsrAI and full-length DltA were used to confirm equal loading of lanes. (B) Cell-associated
FITC-Fg (5 g) was measured using flow cytometry. Representative histograms from at least two independent experiments are shown.
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35000HP (Fig. 3A and B). The levels of expression of DsrA and
DltA were similar in all strains and under all culture conditions
tested (Fig. 3A and data not shown).
The data presented in Fig. 3 show that DsrA appears to be a
major determinant of Fg binding at the surface of viable bacteria
of H. ducreyi class I strain 35000HP. To determine if Fg binding by
DsrA is a general phenomenon among H. ducreyi strains, we ex-
amined class I parent and dsrA mutant strain pairs (8) using the
unlabeled Fg binding assay, measuring cell-associated Fg by West-
ern blotting. In each case, mutational inactivation of dsrA reduced
binding of Fg at the surface of H. ducreyi cells (Fig. 4A). Moreover,
strain HMC21, whose expression of DsrA was lower than that of
the other isolates, bound less Fg than the other tested strains. The
results of the unlabeled Fg binding assay with multiple dsrA mu-
tants strongly suggest that DsrA is the primary mediator of Fg
binding by class I H. ducreyi strains.
Expression of full-length DsrAI or DsrAII renders H. influ-
enzae strain Rd capable of binding Fg. The two classes of H. du-
creyi strains express DsrA proteins (encoded by dsrAI or dsrAII)
that are highly similar in their C-terminal translocator domains
(86% identity) but different in their passenger domains (18). We
previously showed that both classes of DsrA proteins bind Fn and
Vn in the C-terminal regions of their passenger domains (17). To
determine whether class II DsrA proteins are also involved in
binding Fg at the surface of viable bacteria, full-length dsrAI or
dsrAII was expressed in trans from plasmid pUNCH1260 or
pUNCH1296, respectively, in H. influenzae strain Rd, which does
not bind Fn, Vn, or Fg (16). Expression of both DsrAI and DsrAII
conferred Fg binding to H. influenzae Rd, whether it was grown on
CAP or heme plates (Fig. 4B and data not shown). In contrast,
expression of dltAI or an empty vector did not affect Fg binding to
H. influenzae Rd. These findings indicated that despite dissimilar
primary amino acid sequences in their passenger domains, both
DsrAI and DsrAII mediate Fg binding.
A region in the C terminus of the passenger domain of DsrA
interacts with Fg. A panel of DsrAI proteins truncated in their
passenger domains was previously used to determine amino acid
sequences of DsrAI involved in serum resistance as well as Fn and
Vn binding by H. ducreyi (17). These same truncated DsrAI pro-
teins expressed in the H. ducreyi isogenic dsrA mutant were there-
fore used to identify the domain of DsrA bound by Fg using the Fg
binding assay. The two smallest truncated proteins, DsrAI with a
deletion of residues 25 to 170 (DsrAI25–170) and DsrAI25–
158, bound Fg to the same level as a dsrA mutant expressing an
empty vector (Fig. 5). The next longest construct, DsrAI 25–146,
bound Fg to 49% of the level of a strain expressing full-length
DsrAI, and DsrAI 25–133 bound 80% of that level (Fig. 5). Sur-
prisingly, Fg binding by the next-longest truncated DsrAI protein,
DsrAI25–121, was reduced to 50% of the binding of the parent
strain (Fig. 5). Furthermore, larger truncated DsrAI proteins
bound Fg at levels similar to the level of the dsrA mutant express-
ing an empty vector (Fig. 5). These results were not related to the
expression levels of the truncated DsrAI proteins since all but the
smallest constructs, DsrAI25–170 and DsrAI25–158, appeared
to be expressed at levels similar to the level of the full-length DsrAI
(Fig. 5). Reduced surface exposure of truncated DsrAI proteins
also did not correlate with the data obtained in the Fg binding
assay as all truncated DsrAI proteins, except the two smallest ones,
were expressed at levels similar to the level of full-length DsrAI at
the bacterial surface (17; also data not shown).
The above-described results could be explained by improper
folding of the larger truncated DsrA proteins at the surface of H.
ducreyi cells. We postulated that improperly folded DsrA proteins
might block the Fg binding site present closer to the bacterial
membrane. To test this hypothesis, we removed a 13-amino-acid
sequence (LKVLDARISKNKQ) in the C-terminal region of the
passenger domain of DsrA (Fig. 6A). The truncated protein
FIG 4 Both classes of DsrA proteins confer Fg binding. (A) Four different class
I H. ducreyi strains, along with their respective dsrA mutants, were assayed for
Fg binding using Western blotting with 2.5 g of unlabeled Fg. (B) Plasmids
encoding full-length dsrAI, dltAI, dsrAII, or an empty plasmid (pLSSK) were
expressed in the non-Fg-binding strain H. influenzae Rd and tested for binding
to Fg by Western blotting. Ponceau S staining of the nitrocellulose membranes
(data not shown) and Western blotting with anti-recombinant D15 (rD15)
protein were used to ensure equal loading in lanes (36). Shown are represen-
tative blots from at least two independent experiments. Anti-rFL-DsrAI, rabbit
polyclonal antibody elicited to full-length recombinant DsrAI (18).
FIG 5 A sequence in the passenger domain of DsrA may be involved in Fg
binding by H. ducreyi. A panel of truncated DsrA proteins, expressed in an H.
ducreyi dsrA mutant, was tested for Fg binding by Western blotting with 2.5 g
of unlabeled Fg. (Top) Representative Western blot from three independent Fg
binding assays with identical results. The band density from all three assays is
expressed as an average and shown as a percentage of binding by full-length
DsrAI, assigned as 100% binding. (Bottom) Expression of truncated DsrAI
proteins was assessed using a polyclonal Ab developed to full-length DsrAI
(anti-rFL-DsrAI). Ponceau S staining of the nitrocellulose membranes was
used to ensure equal loading of total proteins in all lanes (data not shown).
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DsrAI25–133, which contains this sequence, bound the most Fg
of all truncated proteins, with 80% of WT levels (Fig. 5). Removal
of these amino acids abrogated binding of H. ducreyi to Fg, as
measured using Western blotting (Fig. 6B) and flow cytometry
(Fig. 6C). In contrast, removal of 12-amino-acid sequences in the
translocator domain (MEQNTHNINKLS and NTHNINKLSKEL)
did not affect Fg binding (Fig. 6B and C).
We previously suggested that serum resistance by DsrA might be
due to shielding of H. ducreyi surface determinants by the interaction
of DsrA with large serum components (17). To determine whether Fg
binding is involved in H. ducreyi serum resistance mediated by DsrA,
we measured the survival of the mutants shown in Fig. 6B and C in a
bactericidal assay with 50% NHS. Removal of the sequence LKVLD
ARISKNKQ did not affect survival of H. ducreyi in NHS (Fig. 6D).
Conversely, removal of one of the sequences in the translocator do-
main, NTHNINKLSKEL, rendered the H. ducreyi strain expressing
this mutation susceptible to the bactericidal activity of NHS (Fig. 6D).
Based on these data, we conclude that Fg binding by H. ducreyi is not
involved in serum resistance.
DISCUSSION
In both natural and experimental chancroid, H. ducreyi colocal-
izes with fibrin (5, 6). Fibrin is a vital part of the coagulation
process, which originates from the transformation of the serum
glycoprotein Fg by the action of thrombin (22). Several strains of
H. ducreyi had previously been shown to bind Fg in an agglutina-
tion assay (26). Furthermore, an Fg binding protein had been
identified in the prototypical class I strain 35000HP in an assay with
denatured H. ducreyi proteins (27). Based on this information, we
sought to determine if viable H. ducreyi bacteria interacted with Fg at
the cell surface by incubating soluble Fg with a suspension of H. du-
creyi and measuring the cell-associated Fg using Western blotting and
flow cytometry. We showed that Fg depleted of Fn, plasminogen, and
von Willebrand factor bound the bacterial cell surface in a dose-de-
pendent manner, regardless of the medium used to grow H. ducreyi
(Fig. 1A). This is different from Fn binding by H. ducreyi, which
occurs only when bacteria are grown on heme plates, due to the pres-
ence of Hb in the growth medium that partially inhibits Fn binding by
H. ducreyi (16). Furthermore, the interaction between viable H. du-
creyi bacteria and Fg was specific as unlabeled Fg competed for bind-
ing of FITC- and DIG-labeled Fg to the bacterial cell (Fig. 1B). These
findings indicated that the serum glycoprotein Fg interacts specifi-
cally at the cell surface of H. ducreyi.
In search of bacterial surface proteins that interacted with Fg,
we showed that DIG-Fg bound only two H. ducreyi proteins, DsrA
and DltA (Fig. 2), in ligand blotting against denatured, total cel-
lular proteins from a panel of H. ducreyi OMP mutants. However,
ligand blots may not reflect what occurs at the surface of viable H.
ducreyi bacteria. For example, DltA was shown to interact with
DIG-Fn in ligand blotting, but a dltA mutant was not impaired in
its interaction with Fn in a Fn binding assay using viable H. ducreyi
cells (16). We found the same to be true with Fg since only the
isogenic dsrA mutant was significantly impaired in its binding to
Fg compared to the parent strain in the Fg binding assay with
intact H. ducreyi bacteria (Fig. 3). None of the five other isogenic
mutants tested had reduced binding to Fg, including the mutant that
lacks the previously identified Fg binding protein FgbA. Further-
more, mutation of the dsrA gene in three other class I strains of H.
ducreyi also reduced Fg binding by these strains (Fig. 4A). These re-
sults differ from those for some Gram-positive bacteria like Staphy-
FIG 6 A 13-amino-acid sequence in the C-terminal section of the passenger
domain of DsrAI is involved in Fg binding by H ducreyi. (A) Schematic show-
ing the location of the 13-amino-acid mutation in the DsrA protein. Fg bind-
ing at the surface of dsrA mutants was investigated using both Western blotting
with unlabeled Fg (5 g) (B) and flow cytometry with FITC-Fg (5 g) (C).
Shown are representative blots and histograms from at least three independent
experiments with similar results. (D) Bactericidal assay with 50% NHS. Shown
are means 
 standard deviations of three independent experiments. Survival
below the dotted line indicates a serum-sensitive strain. SS, signal sequence.
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lococcus aureus or group A Streptococcus (GAS) because these patho-
gens express several different Fg binding proteins, and removal of one
Fg binding protein does not alter its surface interactions with Fg (24).
Therefore, our data strongly suggest that DsrAI is a major mediator of
Fg binding at the surface of class I H. ducreyi strains.
Our data also show that DsrAII can mediate Fg binding in class
II H. ducreyi strains (Fig. 4B). Because we have been unable to
make a mutation in class II H. ducreyi strains, we have examined
DsrAII functions by expressing proteins in the dsrA class I H. du-
creyi mutant or H. influenzae strain Rd. Even though DsrAI and
DsrAII share little homology in their passenger domains, our data
show that both proteins can mediate Fg binding in H. influenzae
strain Rd (Fig. 4B). Thus, we conclude that DsrA not only interacts
with Fg at the surface of H. ducreyi but also can confer Fg binding
to a non-Fg-binding heterologous host.
We previously showed that ECM proteins Fn and Vn bind
DsrA in the C-terminal portion of the passenger domain (17). A
short, 53-residue section of the passenger domain of DsrAI, ex-
pressed along with the translocator domain (a truncated DsrA
protein with residues 25 to 121 removed, where amino acids 1 to
21 encompass the leader peptide and 22 to 170 comprise the pas-
senger domain) (Fig. 6A), bound 56 and 100%, respectively, the
levels of Vn and Fn binding by full-length DsrAI (17). Truncated
DsrAI proteins with larger passenger domains bound Vn and Fn at
the same levels as the full-length protein, while constructs with
smaller passenger domains bound Vn and Fn at levels similar to
those of a dsrA isogenic strain expressing an empty vector (17).
Data presented here show that this does not appear to be the case
for Fg binding. Curiously, only the truncated protein with resi-
dues 25 to 133 missing (DsrAI25-133) bound Fg at 80% of the
binding levels of full-length DsrAI (Fig. 5). Interestingly, all other
truncated DsrAI proteins bearing a larger passenger domain than
DsrAI25-133 bound less Fg, with most constructs binding Fg at
background levels. Based on these data, we speculated that the Fg
binding site of DsrA is in the C-terminal portion of the passenger
domain, present in proteins DsrAI25-146 and DsrAI25-133,
encompassing residues LKVLDARISKNKQ (17). When the trun-
cated DsrA protein is small, this portion of the protein either folds
properly and/or is exposed to the surface, enabling its interaction
with Fg. However, as the truncations of the passenger domains get
smaller and the DsrA constructs get larger, their three-dimen-
sional structures are not native and perhaps are subject to im-
proper folding that hides the Fg binding sites. Only when full-
length DsrA is expressed at the bacterial surface is it capable of
adopting a native conformation, and the Fg binding site on DsrA
is once again available for interaction with Fg.
We tested this hypothesis by removing the 13-amino-acid se-
quence LKVLDARISKNKQ, thought to represent the Fg binding
domain in full-length DsrAI, and keeping the rest of the protein
intact (Fig. 6A). Removal of this sequence in DsrA significantly
reduced binding of Fg by H. ducreyi (Fig. 6B and C). Fg binding
was not affected when similar-sized sequences were removed in
the translocator domain of DsrA (Fig. 6B and C). These data in-
dicate that LKVLDARISKNKQ is involved in Fg binding by DsrA.
We are currently investigating the roles of individual amino acids
in this region of DsrA in Fg binding.
The results presented here are consistent with the Fg binding
domains identified in Fg binding proteins from Gram-positive
bacteria. Three staphylococcal proteins, ClfA, FnpbA, and SdrG,
which are critical to pathogenesis of this bacteria, have been
shown to interact with Fg through subdomains N of their A re-
gions (31, 32). Although these subdomains share low amino acid
sequence homology, their secondary structures are highly con-
served (24). This suggests that the binding of Fg by ClfA, FnbpA,
and SdrG involves a conformational epitope (24). This may also
be the case for DsrAI and DsrAII; despite their highly different
passenger domains, both are capable of mediating Fg binding.
However, it is not known at this time if both classes of DsrA pro-
teins share similar secondary structures.
Bauer et al. reported that H. ducreyi expresses an Fg binding
protein termed FgbA (27). The Fg binding phenotype of this lipo-
protein was demonstrated using a ligand blot in which DIG-Fg
bound to solubilized, denatured whole cells and OMP prepara-
tions of class I H. ducreyi strain 35000HP. As shown above, we
were unable to reproduce these results. In our hands, DIG-Fg did
not bind the 18-kDa FgbA protein in ligand blotting, and an fgbA
mutant was not impaired in its interaction with Fg at the surface of
H. ducreyi cells in our unlabeled Fg assay (Fig. 3). The reasons for
these conflicting results are still unclear, especially since the source
of Fg for all experiments in both reports was the same. Differences
in DIG labeling may have denatured Fg, leading to binding of
DIG-Fg to FgbA in the results presented by Bauer et al. However,
a more likely explanation is that differences in H. ducreyi culture
conditions affected protein expression in the two studies. Bauer et
al. used mid-log-phase liquid cultures, whereas we used 16-h-old
H. ducreyi bacteria from CAP. It is possible that FgbA is only
expressed in certain media and/or during certain phases of the
growth cycle of H. ducreyi that were not replicated under the con-
ditions used in our studies.
H. ducreyi is highly resistant to the bactericidal activity of NHS
(7). The presence of the DsrAI protein at the surface of the H.
ducreyi strain prevents binding of bactericidal IgM at the bacterial
cell surface (8). Because classical inhibitors of the complement
system such as Vn and C4BP do not appear to be involved in this
process (8) and because there is a correlation between the size of
DsrA and the amount of IgM bound at the surface of H. ducreyi
(17), we hypothesized that the mechanism of serum resistance by
DsrA involves shielding of target epitopes at the bacterial cell sur-
face. Our results with truncated DsrAI proteins indicate that se-
rum resistance is not associated with Fn or Vn binding to DsrAI
because DsrAI25-133, which retained serum resistance, did not
interact with Fn or Vn (17). However, DsrAI25-133 is the only
truncated protein to interact with Fg at levels similar to the level of
full-length DsrAI (Fig. 5). It was tempting to speculate that a section
of DsrA encompassing the peptide LKVLDARISKNKQ is involved in
serum resistance as Fg binding and serum resistance appear to coin-
cide in that one region of DsrA. However, our results indicate that
larger truncated proteins, which are serum resistant, do not bind Fg.
Furthermore, removal of this peptide resulted in loss of Fg binding
but retention of serum resistance although these levels were on the
edge between serum resistance and susceptibility (53% survival) (Fig.
6D). We therefore conclude that Fg binding is not involved in H.
ducreyi serum resistance mediated by DsrA.
The 236-amino-acid DsrA protein is therefore capable of bind-
ing several serum and ECM proteins, along with binding kerati-
nocytes. Although this multifunctionality has rarely been reported
for an adhesin in a Gram-negative bacteria (33), the M protein of
group A Streptococcus (GAS) has been ascribed multiple func-
tions, some shared with DsrA, including interaction with many
host proteins, like Fg, Fn, IgG, plasminogen, albumin, factor H,
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collagen IV, and C4BP, and inhibition of phagocytosis (24). There
are several similarities between the H. ducreyi DsrA protein and
the M protein of GAS. First, both proteins are relatively small, with
a highly conserved C-terminal domain and more variable N-ter-
minal domain (34, 35). Like many TAAs, M proteins appear as
hair-like fibrils at the surface of the cells although this has not been
specifically shown for DsrA (34, 35). Finally, both proteins have a
coiled-coil domain that appears to be involved in its multiple
functions. M and DsrA proteins also differ. Not all M proteins
appear to have the same functions (35), while both classes of DsrA
proteins have so far been shown to mediate Fg, Fn, and Vn binding
and resistance to the bactericidal activity of NHS. Furthermore, M
proteins contain repeat sequences, whereas DsrA does not appear
to have distinct repeated domains (although many TAAs do) (35).
Finally, both proteins are anchored differently to the bacterial sur-
face as they are expressed in bacteria with (H. ducreyi) and without
(GAS) an outer membrane.
Using two different methods, we show that the Gram-negative
pathogen H. ducreyi interacts with Fg at its bacterial cell surface. This
interaction was specific to Fg since addition of unlabeled Fg, but not
an irrelevant protein, competed for binding of DIG- and FITC-la-
beled Fg at the bacterial surface. This binding was mediated through
the multifunctional TAA DsrA in four different class I H. ducreyi
strains. Furthermore, both classes of DsrA proteins conferred Fg
binding to a heterologous host that cannot bind Fg. A 13-amino-acid
sequence from DsrA was involved in the interaction of Fg with H.
ducreyi. Since Fg binding is critical in the pathogenesis of medically
important Gram-positive bacteria, providing definitive proof that in-
tact, viable H. ducreyi bacteria interact with Fg at their surface furthers
our understanding of the pathogenesis of chancroid. These data sug-
gest that H. ducreyi interacts with serum Fg present in chancroidal
ulcers. These results may also hint that DsrA is the protein that helps
H. ducreyi colocalize with fibrin in the base of the ulcer as fibrinogen
is the precursor to fibrin. We conclude that DsrA is a multifunctional,
surface-exposed TAA involved in binding to several host ligands, in-
cluding Fg.
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